605177 Stock Overview
Zhejiang East Asia Pharmaceutical Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Zhejiang East Asia Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥20.17 |
| 52 Week High | CN¥29.45 |
| 52 Week Low | CN¥14.96 |
| Beta | 0.46 |
| 1 Month Change | 9.03% |
| 3 Month Change | 22.76% |
| 1 Year Change | -22.39% |
| 3 Year Change | -24.93% |
| 5 Year Change | n/a |
| Change since IPO | -55.01% |
Recent News & Updates
Zhejiang East Asia Pharmaceutical's (SHSE:605177) Shareholders Have More To Worry About Than Only Soft Earnings
Nov 06
Zhejiang East Asia Pharmaceutical Co., Ltd.'s (SHSE:605177) Shares Lagging The Market But So Is The Business
Oct 02Recent updates
Zhejiang East Asia Pharmaceutical's (SHSE:605177) Shareholders Have More To Worry About Than Only Soft Earnings
Nov 06Zhejiang East Asia Pharmaceutical Co., Ltd.'s (SHSE:605177) Shares Lagging The Market But So Is The Business
Oct 02Zhejiang East Asia Pharmaceutical's (SHSE:605177) Solid Profits Have Weak Fundamentals
May 06Zhejiang East Asia Pharmaceutical Co., Ltd. (SHSE:605177) Stock Catapults 26% Though Its Price And Business Still Lag The Market
Apr 23Take Care Before Diving Into The Deep End On Zhejiang East Asia Pharmaceutical Co., Ltd. (SHSE:605177)
Feb 28Shareholder Returns
| 605177 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 2.0% | -1.9% | -1.2% |
| 1Y | -22.4% | -1.8% | 11.8% |
Return vs Industry: 605177 underperformed the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 605177 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 605177 volatility | |
|---|---|
| 605177 Average Weekly Movement | 5.6% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 605177 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 605177's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 1,577 | Cheng Chi | www.eapharm.cn |
Zhejiang East Asia Pharmaceutical Co., Ltd. produces and sells pharmaceutical chemicals, tablets, granules, intermediates, and capsules. It offers quinolones synthetic antibacterial agents, antifungal products, gastrointestinal medications, semi-synthetic cephalosporin antibiotics, carbapenem antibiotics, antiviral agents, central nervous system medications, respiratory drugs, antiallergic agents, antineoplastic agents and tumor adjuvant drugs, and other products.
Zhejiang East Asia Pharmaceutical Co., Ltd. Fundamentals Summary
| 605177 fundamental statistics | |
|---|---|
| Market cap | CN¥2.27b |
| Earnings (TTM) | CN¥80.86m |
| Revenue (TTM) | CN¥1.31b |
28.1x
P/E Ratio1.7x
P/S RatioIs 605177 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 605177 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.31b |
| Cost of Revenue | CN¥968.90m |
| Gross Profit | CN¥346.08m |
| Other Expenses | CN¥265.22m |
| Earnings | CN¥80.86m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.72 |
| Gross Margin | 26.32% |
| Net Profit Margin | 6.15% |
| Debt/Equity Ratio | 37.1% |
How did 605177 perform over the long term?
See historical performance and comparisonDividends
1.6%
Current Dividend Yield46%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 07:35 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhejiang East Asia Pharmaceutical Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xiao Wei Lin | Everbright Securities Co. Ltd. |
| Mingrui Wang | Everbright Securities Co. Ltd. |